| 1 | what you can expect | | | | | | | 2 | 0.39% |
| 2 | you can expect partners | | | | | | | 2 | 0.39% |
| 3 | reuse and multichannel outputs | | | | | | | 2 | 0.39% |
| 4 | content reuse and multichannel | | | | | | | 2 | 0.39% |
| 5 | built a modular content | | | | | | | 1 | 0.19% |
| 6 | organization built a modular | | | | | | | 1 | 0.19% |
| 7 | healthcare organization built a | | | | | | | 1 | 0.19% |
| 8 | medical practice tabs academic | | | | | | | 1 | 0.19% |
| 9 | organization medical practice tabs | | | | | | | 1 | 0.19% |
| 10 | services organization medical practice | | | | | | | 1 | 0.19% |
| 11 | financial services organization medical | | | | | | | 1 | 0.19% |
| 12 | healthcare organization pharmaceutical company | | | | | | | 1 | 0.19% |
| 13 | academic healthcare organization pharmaceutical | | | | | | | 1 | 0.19% |
| 14 | studies academic healthcare organization | | | | | | | 1 | 0.19% |
| 15 | invested in us case | | | | | | | 1 | 0.19% |
| 16 | a s e r | | | | | | | 1 | 0.19% |
| 17 | modular content model and | | | | | | | 1 | 0.19% |
| 18 | so invested in us | | | | | | | 1 | 0.19% |
| 19 | being so invested in | | | | | | | 1 | 0.19% |
| 20 | for being so invested | | | | | | | 1 | 0.19% |
| 21 | you for being so | | | | | | | 1 | 0.19% |
| 22 | thank you for being | | | | | | | 1 | 0.19% |
| 23 | turn thank you for | | | | | | | 1 | 0.19% |
| 24 | every turn thank you | | | | | | | 1 | 0.19% |
| 25 | at every turn thank | | | | | | | 1 | 0.19% |
| 26 | it at every turn | | | | | | | 1 | 0.19% |
| 27 | about it at every | | | | | | | 1 | 0.19% |
| 28 | a modular content model | | | | | | | 1 | 0.19% |
| 29 | architecture for real time | | | | | | | 1 | 0.19% |
| 30 | contentasaservice architecture for real | | | | | | | 1 | 0.19% |
| 31 | content based on a | | | | | | | 1 | 0.19% |
| 32 | an entire content supply | | | | | | | 1 | 0.19% |
| 33 | architected an entire content | | | | | | | 1 | 0.19% |
| 34 | team tabs pharmaceutical company | | | | | | | 1 | 0.19% |
| 35 | clinical team tabs pharmaceutical | | | | | | | 1 | 0.19% |
| 36 | the clinical team tabs | | | | | | | 1 | 0.19% |
| 37 | by the clinical team | | | | | | | 1 | 0.19% |
| 38 | managed by the clinical | | | | | | | 1 | 0.19% |
| 39 | algorithms managed by the | | | | | | | 1 | 0.19% |
| 40 | on a library of | | | | | | | 1 | 0.19% |